11月28日,九源基因在港交所正式上市,共发行4539.88万股。经股权结构层层剥茧后发现,九源基因与华东医药紧密相连。李邦良为九源基因的创始人,也是华东医药的前董事长。正是在李邦良的带领下,中美华东与福士生物、台湾裕友建设、香港源裕投资共同设立九源基因。中美华东作为华东医药最重要的子公司,根据IPO前的股权结构,其持股占比21.06%,是九源基因目前最大的股东。因为这层关系,九源基因与华东医药在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.